Latest filing published 09 Sept 2026 for Bio-Rad Laboratories, INC.. Read the official filing
All filings by Norman d. Schwartz on record concern Bio-Rad Laboratories, Inc., in the capacity of chief executive. We count 22 filings; the first trade dates from 2 September 2021 and the latest from 6 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 9 September 2026: an option exercise, in Bio-Rad Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations